CURATING GOOD TIMES
We presently hold medical cannabis licenses in nine states and participate in a variety of ways for each facility, from full ownership and operation to design-build expertise and operational consultation. Our aggressive expansion efforts include seeking licenses in other states and exploring opportunities abroad.
HARVEST IS A NATIONAL ENTERPRISE.
We hold medical cannabis licenses in nine states and have plans to continue expanding throughout the United States and abroad.
10 vertically integrated licenses
7 dispensaries open
2 cultivation & 1 processing site
1 cultivation and processing license
4 dispensary applications pending
4 dispensary licenses
1 dispensary open in Napa
6 dispensary applications
1 processing and manufacturing facility
3 vertically integrated pending medical applications
3 dispensary applications pending
1 cultivation application approved at the local level
2 processing applications pending
1 vertically integrated license definitive documents executed
1 cultivation license
1 processing license
1 cultivation facility operating
1 processing facility under construction
1 dispensary open
1 dispensary license
1 dispensary open
6 additional dispensary licenses to 18 dispensary applications pending
1 cultivation license
3 dispensary licenses
1 processing license pending
1 Harvest also holds <10% minority interests in 4 cultivation licenses, 3 processing licenses and 7 dispensary licenses.
WE UNDERSTAND THE IMPORTANCE OF EDUCATING OUR PATIENTS.
However, we don’t just disseminate knowledge; we also create it. Our research team drives to learn more about medical cannabis through meticulous academic research.
MEDICAL MARIJUANA RESEARCH INSTITUTE
Founded by Drs. Troutt and DiDonato, the Medical Marijuana Research Institute is our research division, and is dedicated to contributing to the academic literature on medical marijuana. The Institute’s first article was recently published in the Journal of Psychoactive Drugs, and focuses on the characteristics and experiences of medical marijuana patients in Arizona. Conducting such research establishes Harvest as an industry leader in both business and academia.
ARIZONA PATIENT CHARACTERISTICS
Published in the Journal of Psychoactive Drugs, the Institute’s first article was the first study to examine medical cannabis patients living in Arizona. The findings showed that legalization has had many positive effects on patient outcomes, including increased feelings of safety, improved product knowledge, and greater product effectiveness
BYPRODUCTS OF VAPORIZED CUTTING AGENTS
The second study, published in the Journal of Alternative and Complementary Medicine, examined the byproducts produced by vaporizing cannabis-oil cutting agents. The results showed that PEG 400 produced formaldehyde at levels comparable to cigarette smoke, whereas MCT and VG produced negligible levels of harmful byproducts.
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty six hundred dollars for Harvest Health & Recreation Inc. current news coverage by a non-affiliated third party. FNMG HOLDS NO SHARES OF Harvest Health & Recreation Inc.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.